methylprednisolone and Ambulation Difficulty

methylprednisolone has been researched along with Ambulation Difficulty in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernando, S; Herkes, G; Li, J	1

Reviews

1 review(s) available for methylprednisolone and Ambulation Difficulty

Article	Year
Use of infliximab and other biologics in Behçet disease. Internal medicine journal, 2014, Volume: 44, Issue:1 Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Biological Products; Combined Modality Therapy; Delayed Diagnosis; Disease Progression; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Infliximab; Male; Methylprednisolone; Mobility Limitation; Paraparesis; Plasmapheresis; Prednisolone; Remission Induction; Tumor Necrosis Factor-alpha	2014

Article

Year

Use of infliximab and other biologics in Behçet disease.

Internal medicine journal, 2014, Volume: 44, Issue:1

Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Biological Products; Combined Modality Therapy; Delayed Diagnosis; Disease Progression; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Infliximab; Male; Methylprednisolone; Mobility Limitation; Paraparesis; Plasmapheresis; Prednisolone; Remission Induction; Tumor Necrosis Factor-alpha

2014